GNH USA

Europe — EMA

Lamivudin/Zidovudin Aurobindo (Zidovudine, Lamivudine)

GNH USA supplies Lamivudin/Zidovudin Aurobindo (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine, the active ingredient in Lamivudin/Zidovudin Aurobindo, is a nucleoside reverse transcriptase inhibitor presented as a tablet for oral use. It treats HIV-1 infection in adults and children. GNH USA supplies Lamivudin/Zidovudin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudin/Zidovudin Aurobindo, a nucleoside reverse transcriptase inhibitor, is indicated for the treatment of HIV-1 infection.

- HIV‑1 infection (adults): reduces viral replication when used with other antiretrovirals. - HIV‑1 infection (children): provides pediatric dosing options within combination regimens. - HIV‑1 infection (treatment‑experienced patients): helps achieve viral suppression in the presence of resistance to other agents.

What are the side effects of Zidovudine, Lamivudine?

Adverse reactions may occur with Lamivudin/Zidovudin Aurobindo. Patients should be monitored for both common and serious events.

Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea

Serious or Rare Side Effects: - Severe lactic acidosis - Hepatotoxicity - Hypersensitivity reactions, including Stevens‑Johnson syndrome

What precautions apply to Zidovudine, Lamivudine?

Lamivudin/Zidovudin Aurobindo requires careful clinical monitoring to minimise risks.

- Monitor liver function: obtain baseline and periodic liver enzyme tests. - Assess renal function: adjust therapy if creatinine clearance is reduced. - Screen for anemia: perform complete blood counts before and during treatment. - Avoid use in patients with known hypersensitivity to lamivudine or zidovudine. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Zidovudine, Lamivudine interact with?

Lamivudin/Zidovudin Aurobindo can interact with several medicines; clinicians should review patient regimens.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: additive mitochondrial toxicity. - Alcohol: may exacerbate hepatotoxicity.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs (e.g., aminoglycosides): monitor renal function. - Anticoagulants (e.g., warfarin): monitor INR. - Live vaccines: assess risk before administration.

Frequently asked questions

What is Lamivudin/Zidovudin Aurobindo used for?+
Lamivudin/Zidovudin Aurobindo is a fixed‑dose combination of lamivudine and zidovudine used as part of antiretroviral therapy to treat HIV‑1 infection in adults and children. It works together with other antiretrovirals to lower viral load and improve immune function.
How does lamivudine work in this combination?+
Lamivudine is a nucleoside analogue that, after intracellular phosphorylation, mimics natural nucleosides and is incorporated into viral DNA by reverse transcriptase. This incorporation halts DNA chain elongation, preventing the virus from replicating effectively.
What is the usual dose of Lamivudin/Zidovudin Aurobindo?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s age, weight, renal function, and overall treatment plan. Healthcare professionals should follow current HIV treatment guidelines when selecting the appropriate regimen.
Is Lamivudin/Zidovudin safe during pregnancy or breastfeeding?+
Safety data for lamivudine and zidovudine in pregnancy are limited, and the product’s pregnancy category is not established. Clinicians must weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.
How do I order Lamivudin/Zidovudin Aurobindo from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Lamivudin/Zidovudin compare with other antiretroviral options?+
Compared with single‑agent regimens, the lamivudine/zidovudine combination offers a convenient two‑drug tablet that reduces pill burden. While newer agents may have improved resistance profiles, this combination remains a cost‑effective option in many treatment guidelines, especially where access to newer drugs is limited.
What are the storage and handling requirements for this product?+
Lamivudin/Zidovudin Aurobindo tablets should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer.
How is Lamivudin/Zidovudin administered?+
The medication is taken orally, usually with or without food, as directed by the prescriber. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare provider.
What are the most serious risks associated with this therapy?+
Serious adverse events include severe lactic acidosis, hepatotoxicity, and hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should be educated to report symptoms like unexplained fatigue, abdominal pain, jaundice, or skin rash promptly.
Who should not use Lamivudin/Zidovudin Aurobindo?+
Individuals with known hypersensitivity to lamivudine, zidovudine, or any component of the tablet should avoid this medication. Clinicians should also exercise caution in patients with significant liver disease, severe anemia, or mitochondrial disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Puren Pharma Gmbh & Co. Kg
Origin
EU

Related products

Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU